BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11827905)

  • 1. Clinical efficacy of co-trimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in Pakistan.
    Catchup Study Group
    Arch Dis Child; 2002 Feb; 86(2):113-8. PubMed ID: 11827905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Co-trimoxazole Study Group.
    Straus WL; Qazi SA; Kundi Z; Nomani NK; Schwartz B
    Lancet; 1998 Jul; 352(9124):270-4. PubMed ID: 9690406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2-59 Months in Pakistan: A Cluster-randomized Trial.
    Sadruddin S; Khan IUH; Fox MP; Bari A; Khan A; Thea DM; Khan A; Khan I; Ahmad I; Qazi SA
    Clin Infect Dis; 2019 Jul; 69(3):397-404. PubMed ID: 30596964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial.
    Bari A; Sadruddin S; Khan A; Khan Iu; Khan A; Lehri IA; Macleod WB; Fox MP; Thea DM; Qazi SA
    Lancet; 2011 Nov; 378(9805):1796-803. PubMed ID: 22078721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of standard versus double dose cotrimoxazole for childhood pneumonia in Pakistan.
    Rasmussen ZA; Bari A; Qazi S; Rehman G; Azam I; Khan S; Aziz F; Rafi S; Roghani MT; Iqbal I; Nagi AG; Hussain W; Bano N; van Latum LJ; Khan M;
    Bull World Health Organ; 2005 Jan; 83(1):10-9. PubMed ID: 15682244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial.
    Soofi S; Ahmed S; Fox MP; MacLeod WB; Thea DM; Qazi SA; Bhutta ZA
    Lancet; 2012 Feb; 379(9817):729-37. PubMed ID: 22285055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of 3-day amoxycillin vs. 5-day co-trimoxazole in the treatment of non-severe pneumonia in children aged 2-59 months of age: a multi-centric open labeled trial.
    Awasthi S; Agarwal G; Singh JV; Kabra SK; Pillai RM; Singhi S; Nongkynrih B; Dwivedi R; More VB; Kulkarni M; Niswade AK; Bharti B; Ambast A; Dhasmana P;
    J Trop Pediatr; 2008 Dec; 54(6):382-9. PubMed ID: 18611959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2-59 months: a multicenter, double-blind, randomized, placebo-controlled trial in pakistan.
    Hazir T; Nisar YB; Abbasi S; Ashraf YP; Khurshid J; Tariq P; Asghar R; Murtaza A; Masood T; Maqbool S
    Clin Infect Dis; 2011 Feb; 52(3):293-300. PubMed ID: 21189270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial.
    Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group
    Lancet; 2002 Sep; 360(9336):835-41. PubMed ID: 12243918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial.
    Hazir T; Fox LM; Nisar YB; Fox MP; Ashraf YP; MacLeod WB; Ramzan A; Maqbool S; Masood T; Hussain W; Murtaza A; Khawar N; Tariq P; Asghar R; Simon JL; Thea DM; Qazi SA;
    Lancet; 2008 Jan; 371(9606):49-56. PubMed ID: 18177775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan.
    Hazir T; Qazi SA; Bin Nisar Y; Maqbool S; Asghar R; Iqbal I; Khalid S; Randhawa S; Aslam S; Riaz S; Abbasi S
    Arch Dis Child; 2007 Apr; 92(4):291-7. PubMed ID: 16547082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study.
    Addo-Yobo E; Chisaka N; Hassan M; Hibberd P; Lozano JM; Jeena P; MacLeod WB; Maulen I; Patel A; Qazi S; Thea DM; Nguyen NT
    Lancet; 2004 Sep 25-Oct 1; 364(9440):1141-8. PubMed ID: 15451221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trial of co-trimoxazole versus procaine penicillin with ampicillin in treatment of community-acquired pneumonia in young Gambian children.
    Campbell H; Byass P; Forgie IM; O'Neill KP; Lloyd-Evans N; Greenwood BM
    Lancet; 1988 Nov; 2(8621):1182-4. PubMed ID: 2903386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community case management of fast-breathing pneumonia with 3 days oral amoxicillin vs 5 days cotrimoxazole in children 2-59 months of age in rural Pakistan: A cluster randomized trial.
    Ahmed S; Ariff S; Muhammed S; Rizvi A; Ahmed I; Soofi SB; Bhutta ZA
    J Glob Health; 2022 Dec; 12():04097. PubMed ID: 36579494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of hospital versus home based therapy with oral amoxicillin for severe pneumonia in children aged 3 - 59 months: The IndiaCLEN Severe Pneumonia Oral Therapy (ISPOT) Study.
    Patel AB; Bang A; Singh M; Dhande L; Chelliah LR; Malik A; Khadse S;
    BMC Pediatr; 2015 Nov; 15():186. PubMed ID: 26577943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial.
    Bowen AC; Tong SY; Andrews RM; O'Meara IM; McDonald MI; Chatfield MD; Currie BJ; Carapetis JR
    Lancet; 2014 Dec; 384(9960):2132-40. PubMed ID: 25172376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial.
    Pokharel S; Basnyat B; Arjyal A; Mahat SP; Kc RK; Bhuju A; Poudyal B; Kestelyn E; Shrestha R; Phuong DNT; Thapa R; Karki M; Dongol S; Karkey A; Wolbers M; Baker S; Thwaites G
    Trials; 2017 Oct; 18(1):450. PubMed ID: 28969659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial of co-trimoxazole versus procaine penicillin G and benzathin penicillin + procaine penicillin G in the treatment of childhood pneumonia.
    Sidal M; Oğuz F; Unüvar A; Sarbat G; Neyzi O
    J Trop Pediatr; 1994 Oct; 40(5):301-4. PubMed ID: 7807627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial.
    Ginsburg AS; Mvalo T; Nkwopara E; McCollum ED; Ndamala CB; Schmicker R; Phiri A; Lufesi N; Izadnegahdar R; May S
    JAMA Pediatr; 2019 Jan; 173(1):21-28. PubMed ID: 30419120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP).
    Jehan F; Nisar MI; Kerai S; Brown N; Balouch B; Hyder Z; Ambler G; Ginsburg AS; Zaidi AK
    BMC Infect Dis; 2016 Jan; 16():13. PubMed ID: 26758747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.